RNA for therapy
Registration number: CZ.02.01.01/00/22_008/0004575
Programme Johannes Amos Comenius
Call number 02_22_008 Excellent research
Priority 1 - Research and Development
Project is co-funded by the European Union
Beneficiary: Institute of Organic Chemistry and Biochemistry of the CAS
Project partners: Biology Centre of the CAS; Masaryk University; Institute of Microbiology of the CAS; Charles University; Institute of Molecular Genetics of the CAS
Principal investigators (BC CAS): doc. RNDr. Alena Panicucci Zíková, Ph.D.; RNDr. Zdeněk Paris, Ph.D.; Mgr. Ondřej Gahura, Ph.D.
Total project budget: 499 640 882, 63 CZK
Implementation period: 1.1.2024 - 31.10.2028
Co-financing by BC CAS: 5%
Project description:
The project aims to develop a Czech-driven research and innovation ecosystem in the field of RNA medicine and expand therapeutic potential of RNA, which emerged in recent years as a remarkable therapeutic tool for personalized medicine and immunotherapy, as well as to address genetic, infectious, and chronic diseases linked to RNA metabolism. The project combines cutting-edge research on key molecular mechanisms in RNA biology and the translation of the knowledge into practical applications.
